Tech Company Financing Transactions
D&D Pharmatech Funding Round
D&D Pharmatech, based in Germantown, scored $137.1 million from Octave Life Sciences, Smilegate Investment and InterVest.
Transaction Overview
Company Name
Announced On
8/16/2019
Transaction Type
Venture Equity
Amount
$137,100,000
Round
Series B
Investors
Octave Life Sciences (Lead Investor)
Smilegate Investment (Lead Investor)
Proceeds Purpose
With this funding, we will continue executing on our strategy to develop truly novel approaches to treat challenging diseases with significant unmet need.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20271 Goldenrod Ln. 20876
Germantown, MD 20876
USA
Germantown, MD 20876
USA
Phone
Undisclosed
Website
Email Address
Overview
D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Ted Dawson
Founder
Kang Lee
Founder
Seulki Lee
Founder
Martin Pomper
Founder
Viktor Roschke
Browse more venture capital transactions:
Prev: 8/16/2019: UrbanStems venture capital transaction
Next: 8/16/2019: Nomad Health venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs